Isoform | Protein Position | Transcript Position | Chromosomal Position (HG38) | Chromosomal Position (HG19) |
---|---|---|---|---|
IC | 19938 | 60037;60038;60039 | chr2:178592092;178592091;178592090 | chr2:179456819;179456818;179456817 |
N2AB | 18297 | 55114;55115;55116 | chr2:178592092;178592091;178592090 | chr2:179456819;179456818;179456817 |
N2A | 17370 | 52333;52334;52335 | chr2:178592092;178592091;178592090 | chr2:179456819;179456818;179456817 |
N2B | 10873 | 32842;32843;32844 | chr2:178592092;178592091;178592090 | chr2:179456819;179456818;179456817 |
Novex-1 | 10998 | 33217;33218;33219 | chr2:178592092;178592091;178592090 | chr2:179456819;179456818;179456817 |
Novex-2 | 11065 | 33418;33419;33420 | chr2:178592092;178592091;178592090 | chr2:179456819;179456818;179456817 |
Novex-3 | None | None | chr2:None | chr2:None |
SNV | RS | DUET |
PolyPhen-2 |
Condel |
Rhapsody |
REVEL |
MVP |
Source |
MAF |
Disease |
Zygosity |
Site annotation |
mCSM PPI |
Predicted PPI site |
Comments |
AFR |
AMR |
AMS |
ASJ |
EAS |
EUR |
FIN |
MDE |
NFE |
SAS |
OTH |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A/T | rs755204306 | -1.166 | 1.0 | N | 0.697 | 0.268 | 0.46614307118 | gnomAD-2.1.1 | 8.07E-06 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 3.27E-05 | None | 0 | 8.92E-06 | 0 |
A/T | rs755204306 | -1.166 | 1.0 | N | 0.697 | 0.268 | 0.46614307118 | gnomAD-3.1.2 | 1.32E-05 | None | None | None | None | N | None | 0 | 0 | 0 | 0 | 0 | None | 0 | 0 | 2.94E-05 | 0 | 0 |
A/T | rs755204306 | -1.166 | 1.0 | N | 0.697 | 0.268 | 0.46614307118 | Sasaki (2020) | None | Other | comp het with A9980T, R29293C | None | None | N | Genetic analysis of 2 siblings with asymmetric facial and limb weakness; variant prioritisation; no validation | None | None | None | None | None | None | None | None | None | None | None |
A/T | rs755204306 | -1.166 | 1.0 | N | 0.697 | 0.268 | 0.46614307118 | gnomAD-4.0.0 | 3.59616E-05 | None | None | None | None | N | None | 1.33568E-05 | 0 | None | 0 | 3.58568E-04 | None | 0 | 0 | 2.54347E-05 | 8.78677E-05 | 4.80708E-05 |
A/V | rs1187337182 | 0.677 | 0.992 | N | 0.639 | 0.354 | None | gnomAD-2.1.1 | 1.43E-05 | None | None | None | None | N | None | 0 | 0 | None | 0 | 0 | None | 0 | None | 0 | 3.14E-05 | 0 |
A/V | rs1187337182 | 0.677 | 0.992 | N | 0.639 | 0.354 | None | gnomAD-3.1.2 | 4.61E-05 | None | None | None | None | N | None | 2.41E-05 | 0 | 0 | 0 | 0 | None | 0 | 0 | 8.83E-05 | 0 | 0 |
A/V | rs1187337182 | 0.677 | 0.992 | N | 0.639 | 0.354 | None | gnomAD-4.0.0 | 7.25416E-05 | None | None | None | None | N | None | 2.67115E-05 | 0 | None | 0 | 0 | None | 0 | 0 | 9.58025E-05 | 0 | 3.20451E-05 |
SAV |
AlphaMissense (IC) |
AlphaMissense Class (IC) |
AlphaMissense (N2AB) |
AlphaMissense Class (N2AB) |
mCSM |
mCSM class |
PolyPhen-2 |
PolyPhen-2 Class |
Rhapsody |
Rhapsody Class |
Condel |
Condel Score |
Site annotation |
mCSM PPI |
Predicted PPI site |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A/C | 0.4009 | ambiguous | 0.3985 | ambiguous | -0.427 | Destabilizing | 1.0 | D | 0.768 | deleterious | None | None | None | None | N |
A/D | 0.9322 | likely_pathogenic | 0.9599 | pathogenic | -2.171 | Highly Destabilizing | 1.0 | D | 0.837 | deleterious | N | 0.496180732 | None | None | N |
A/E | 0.8581 | likely_pathogenic | 0.9117 | pathogenic | -1.901 | Destabilizing | 1.0 | D | 0.804 | deleterious | None | None | None | None | N |
A/F | 0.5768 | likely_pathogenic | 0.6203 | pathogenic | -0.49 | Destabilizing | 0.999 | D | 0.839 | deleterious | None | None | None | None | N |
A/G | 0.3079 | likely_benign | 0.3251 | benign | -1.244 | Destabilizing | 0.999 | D | 0.656 | neutral | N | 0.493739 | None | None | N |
A/H | 0.8909 | likely_pathogenic | 0.9242 | pathogenic | -1.951 | Destabilizing | 1.0 | D | 0.863 | deleterious | None | None | None | None | N |
A/I | 0.2631 | likely_benign | 0.2641 | benign | 0.737 | Stabilizing | 0.994 | D | 0.743 | deleterious | None | None | None | None | N |
A/K | 0.9477 | likely_pathogenic | 0.967 | pathogenic | -0.77 | Destabilizing | 1.0 | D | 0.8 | deleterious | None | None | None | None | N |
A/L | 0.2375 | likely_benign | 0.2579 | benign | 0.737 | Stabilizing | 0.504 | D | 0.457 | neutral | None | None | None | None | N |
A/M | 0.4273 | ambiguous | 0.453 | ambiguous | 0.539 | Stabilizing | 0.999 | D | 0.825 | deleterious | None | None | None | None | N |
A/N | 0.8479 | likely_pathogenic | 0.8854 | pathogenic | -1.264 | Destabilizing | 1.0 | D | 0.838 | deleterious | None | None | None | None | N |
A/P | 0.7636 | likely_pathogenic | 0.7953 | pathogenic | 0.295 | Stabilizing | 1.0 | D | 0.812 | deleterious | D | 0.523097975 | None | None | N |
A/Q | 0.8138 | likely_pathogenic | 0.8625 | pathogenic | -0.932 | Destabilizing | 1.0 | D | 0.806 | deleterious | None | None | None | None | N |
A/R | 0.901 | likely_pathogenic | 0.9348 | pathogenic | -1.154 | Destabilizing | 1.0 | D | 0.813 | deleterious | None | None | None | None | N |
A/S | 0.22 | likely_benign | 0.2324 | benign | -1.611 | Destabilizing | 1.0 | D | 0.646 | neutral | N | 0.470354826 | None | None | N |
A/T | 0.1964 | likely_benign | 0.177 | benign | -1.199 | Destabilizing | 1.0 | D | 0.697 | prob.neutral | N | 0.511707545 | None | None | N |
A/V | 0.1306 | likely_benign | 0.1283 | benign | 0.295 | Stabilizing | 0.992 | D | 0.639 | neutral | N | 0.383639086 | None | None | N |
A/W | 0.9191 | likely_pathogenic | 0.9445 | pathogenic | -1.416 | Destabilizing | 1.0 | D | 0.854 | deleterious | None | None | None | None | N |
A/Y | 0.7935 | likely_pathogenic | 0.8413 | pathogenic | -0.716 | Destabilizing | 1.0 | D | 0.857 | deleterious | None | None | None | None | N |
Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.